(S)-(Tetrahydro-2H-pyran-3-yl)methyl benzoate, 95+%, 1g

(S)-2-(((tert-Butoxycarbonyl)amino)methyl)pentanoic acid, 98%, 250mg

4-Amino-2-chloro-5-nitrobenzonitrile, 97%, 1g

[(anthracen-9-yl)methyl](propyl)amine, 95.0%, 10g

1-METHYL-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE, 95.0%, 100mg

Yttrium(III) oxide, ROTI®METIC 99.999% (5N), 10 g, plastic packaging.

Thalidomide-propargyl, 10mg

Morpholin-4-ylacetic acid hydrochloride, 97.0%, 1g

dimethyl octanebis(imidoate) dihydrochloride, 96.0%, 1g

2-Amino-5-bromobenzaldehyde, 95.0%, 10g

Methyl 3-bromo-2-methoxybenzoate, 95.0%, 1g

Ethyl 1H-pyrrole-3-carboxylate, 95.0%, 5g

1,3-Dibromo-5-iodobenzene>98.0%(GC)5g